Shares of Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) reached a new 52-week high on Thursday. The company traded as high as $77.39 and last traded at $77.39, with a volume of 305 shares trading hands. The stock had previously closed at $76.89.
Lonza Group Stock Performance
The stock’s 50 day simple moving average is $70.73 and its 200 day simple moving average is $67.21. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.66 and a quick ratio of 1.21.
Lonza Group Company Profile
Lonza Group AG is a Swiss contract development and manufacturing organization (CDMO) that supports pharmaceutical and biotechnology companies throughout the life cycle of their products. The company provides research, process development, testing, manufacturing, and regulatory support for therapies and other healthcare products, helping customers advance programs from early development through commercial production.
Lonza’s activities include the development and manufacture of biologics, small-molecule medicines, and cell and gene therapies.
Featured Articles
- Five stocks we like better than Lonza Group
- The Factories Behind AI Servers Just Raised Their Outlooks—3 Contract Manufacturers to Watch
- MarketBeat Week in Review – 10/26 – 10/30
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
